NewAmsterdam Pharma Company N.V.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $769.3M
Liabilities Breakdown FY2025
Total Liabilities: $85.9M
Asset Breakdown
Total Assets: $769.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $490.0M | 63.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $383.0K | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $278.9M | 36.3% |
Liabilities Breakdown
Total Liabilities: $85.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.0M | 10.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $76.9M | 89.6% |